Ambu A/S (OTCMKTS:AMBBY) Short Interest Down 33.3% in September

Ambu A/S (OTCMKTS:AMBBY) saw a large decline in short interest in September. As of September 15th, there was short interest totalling 200 shares, a decline of 33.3% from the August 31st total of 300 shares. Based on an average trading volume of 400 shares, the days-to-cover ratio is currently 0.5 days.

Ambu A/S Price Performance

Shares of AMBBY remained flat at $19.60 during trading hours on Friday. The stock had a trading volume of 1 shares, compared to its average volume of 583. The firm has a fifty day moving average of $20.07 and a 200 day moving average of $18.62. The company has a current ratio of 2.52, a quick ratio of 1.51 and a debt-to-equity ratio of 0.09. The company has a market cap of $4.61 billion and a price-to-earnings ratio of 98.00. Ambu A/S has a one year low of $9.45 and a one year high of $22.65.

Ambu A/S (OTCMKTS:AMBBY) last released its quarterly earnings data on Friday, August 30th. The company reported $0.07 earnings per share for the quarter. Ambu A/S had a net margin of 8.55% and a return on equity of 8.09%. The firm had revenue of $199.56 million for the quarter.

About Ambu A/S

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.